Gliadin encapsulated PCOs nanoformulation: An effective therapeutic option for metastatic breast cancer
Breast carcinoma ranks as one of the most dominant cause of mortality among women worldwide, with metastatic breast cancer posing a significant therapeutic challenge due to its high fatality rate and propensity to spread to critical organs like the lungs and brain. Despite their effectiveness, curre...
Saved in:
Main Authors: | Sant Lal, Monika Kataria, Neeraj Dilbaghi |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-06-01
|
Series: | Hybrid Advances |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2773207X25000247 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evaluating the impact of a tertiary multidisciplinary meeting in metastatic breast cancer: A prospective study
by: Belinda Sassé, et al.
Published: (2025-02-01) -
SleepNow – A combined cognitive behavioral therapy for insomnia and physical exercise intervention in men with metastatic prostate cancer: results from a feasibility randomized controlled trial
by: Beverley Lim Høeg, et al.
Published: (2025-02-01) -
Immunotherapy in metastatic renal cell carcinoma: Insights from a Dutch nationwide cohort
by: Hilin Yildirim, et al.
Published: (2025-02-01) -
A patient-led survey on information and communication needs of patients with metastatic breast cancer in Ireland and Northern Ireland (CTRIAL-IE 23–05)
by: Siobhan Gaynor, et al.
Published: (2025-02-01) -
Polycystic ovary syndrome (PCOS): progress towards a better understanding and treatment of the syndrome
by: Mimouni, Nour El Houda, et al.
Published: (2024-04-01)